Reviewed by the Help Dementia Editorial Team — our editors review every article for accuracy against guidance from the National Institute on Aging, the Alzheimer’s Association, and peer-reviewed sources.
Yes, dementia risk does differ by race and ethnicity, and the disparities are significant. Research consistently shows that African Americans develop dementia at higher rates than white Americans, with some studies indicating they are nearly twice as likely to develop Alzheimer’s disease. These differences are not random or inevitable—they reflect a complex interplay of genetic factors, access to healthcare, cardiovascular health, education levels, and decades of structural inequality that affect how disease develops and is detected in different communities.
The disparities in dementia risk are not simply about biology. When researchers control for education, income, and healthcare access, some of the differences narrow, suggesting that social and economic factors play a powerful role alongside any genetic predisposition. A person of color with adequate healthcare, stable housing, and higher education has a different risk profile than someone in the same racial group without those resources. Understanding why these differences exist is essential for anyone concerned with brain health, whether you’re a patient, caregiver, or family member navigating dementia prevention.
Table of Contents
- How Does Dementia Risk Vary Across Different Racial Groups?
- Healthcare Access and Diagnostic Disparities in Dementia Care
- The Role of Cardiovascular Disease and Other Health Conditions
- Socioeconomic Factors, Education, and Cognitive Reserve
- Genetic Factors and APOE Status in Different Populations
- Environmental Factors and Neighborhood Health
- Advancing Research and Improving Outcomes for All Communities
- Conclusion
How Does Dementia Risk Vary Across Different Racial Groups?
African Americans have the highest documented dementia risk among all racial groups in the United States. Studies show that African Americans aged 65 and older have dementia prevalence rates ranging from 8% to 12%, compared to about 5% to 8% among white Americans. Hispanic and Latino populations also show elevated risk in some studies, though the data is less consistent across different research cohorts. Asian Americans and Pacific Islanders generally show lower dementia risk in large studies, though research in these communities is more limited, and some smaller studies suggest variation by country of origin.
The reasons for these differences are multifaceted. One major factor is the higher prevalence of cardiovascular disease and its risk factors—hypertension, diabetes, and obesity—in African American communities. Because cardiovascular disease and vascular damage are direct pathways to dementia, communities with higher rates of these conditions face compounded dementia risk. Additionally, stroke is more common in African American adults, and strokes significantly increase dementia risk. Another contributing factor is healthcare disparities: studies show that African Americans are less likely to be screened for cognitive decline, meaning dementia may be diagnosed later when more brain damage has already occurred.
Healthcare Access and Diagnostic Disparities in Dementia Care
One of the most troubling aspects of racial disparities in dementia is that they are partly invisible due to underdiagnosis. African Americans are more likely to have dementia that goes unrecognized because they may have less regular contact with healthcare providers who screen for cognitive changes. When they do receive a diagnosis, it often comes later in the disease progression, meaning they miss opportunities for earlier intervention and treatment. This diagnostic gap means that official statistics may actually underestimate the true prevalence of dementia in Black communities. Healthcare quality differences compound this problem.
A person with newly diagnosed dementia needs access to specialists (neurologists or geriatricians), medications that can slow cognitive decline, and coordinated care plans. These resources are not equally distributed. Black patients are less likely to see a cognitive specialist after diagnosis and less likely to be prescribed disease-modifying medications. Additionally, some cognitive screening tools have been developed and validated primarily in white populations, which can lead to misclassification of cognitive status in other groups. This limitation in diagnostic tools means that some people from racial minorities may be told they don’t have cognitive impairment when they actually do, or vice versa.
The Role of Cardiovascular Disease and Other Health Conditions
Cardiovascular disease is one of the strongest links between race, ethnicity, and dementia risk. African Americans have higher rates of hypertension starting earlier in life, and hypertension damages blood vessels in the brain over decades, contributing to vascular dementia and mixed dementia (a combination of Alzheimer’s pathology and vascular damage). The prevalence of hypertension is about 54% in non-Hispanic Black adults aged 40 and older, compared to 42% in non-Hispanic white adults. Over a lifetime, this difference in blood pressure control translates into significantly different brain health outcomes.
Diabetes is another critical factor. African Americans are at higher risk for type 2 diabetes, and diabetes significantly increases the risk of cognitive decline and dementia. The combination of diabetes and hypertension—common in African American populations—is particularly damaging to brain blood vessels. Other conditions that contribute to disparities include chronic kidney disease, heart disease, and sleep apnea, all of which are more prevalent in African American communities and all of which increase dementia risk. It’s important to note that these conditions are not inherent to any racial group; rather, they reflect differences in healthcare access, nutritional environments, stress exposure, and other social determinants of health.
Socioeconomic Factors, Education, and Cognitive Reserve
Education level is one of the strongest predictors of dementia risk, and educational disparities between racial groups contribute to differences in dementia rates. People with higher educational attainment have greater “cognitive reserve”—the brain’s ability to compensate for damage and maintain function despite pathology. Someone with a college degree who develops early Alzheimer’s pathology might not show cognitive symptoms for years, while someone with less formal education might show decline sooner. Since African Americans and Hispanic Americans have historically had lower average education levels due to segregation and systemic barriers, this compounds dementia risk in these communities.
Income and socioeconomic status also affect dementia risk through multiple pathways. Lower-income individuals are more likely to have untreated chronic diseases, live in neighborhoods with less access to healthy food options, experience higher chronic stress, have fewer cognitive enrichment opportunities, and work in jobs with greater physical and chemical exposures that may damage the brain. The tradeoff is that improving educational access and economic opportunity would address not just dementia risk, but many other health disparities simultaneously—these are foundational interventions. However, such changes require systemic action beyond individual health decisions.
Genetic Factors and APOE Status in Different Populations
Genetic variation does play a role in dementia risk, but the picture is more complicated than simple racial genetics. The APOE4 gene variant is a strong risk factor for Alzheimer’s disease, and the frequency of this variant differs by ancestry. However, the differences are not as dramatic as once thought, and APOE4 status does not fully explain racial disparities in dementia. Some research suggests that APOE4 may have a stronger predictive effect in white populations than in Black populations, or that other genetic factors play larger roles in some communities.
One important limitation is that most genetic research on dementia has been conducted in people of European ancestry. This means we may not fully understand the genetic risk factors in other populations, and screening tools that rely on European ancestry genetics may be less accurate for other groups. Additionally, gene-environment interactions matter enormously—someone with a genetic risk factor who has good healthcare, treatment of cardiovascular disease, and cognitive engagement may never develop dementia, while someone with the same genes in a different environment might develop severe dementia. The genetic story is never just about the genes.
Environmental Factors and Neighborhood Health
The neighborhood where someone lives throughout their life affects dementia risk in ways that are just beginning to be understood. People living in neighborhoods with high pollution levels, limited access to green space, high violence and chronic stress, and poor food environments face elevated dementia risk. These neighborhood factors are not randomly distributed—they reflect the legacy of redlining and ongoing segregation, which means communities of color have historically been concentrated in neighborhoods with greater environmental stressors.
Research has shown that air pollution exposure is associated with cognitive decline and accelerated brain aging, and African American and Latino Americans have higher average exposure to air pollution due to living closer to highways, industrial facilities, and other pollution sources. Similarly, access to parks and opportunities for physical exercise, which reduce dementia risk, varies by neighborhood affluence and race. These environmental factors are modifiable—improving neighborhood health through policy changes, urban planning, and environmental justice efforts could reduce dementia risk broadly, with particularly large benefits for communities that have faced the greatest environmental burden.
Advancing Research and Improving Outcomes for All Communities
The field of dementia research is beginning to acknowledge that most large studies have underrepresented people of color, leading to knowledge gaps about dementia in these populations. Newer research initiatives are intentionally recruiting diverse participants and conducting more rigorous analyses of how risk factors operate differently across groups.
However, this research is still in early stages, and much remains unknown about optimal prevention and treatment strategies for different populations. Closing disparities in dementia risk will require action on multiple fronts: improving access to preventive healthcare and dementia screening in underserved communities, addressing cardiovascular disease disparities, ensuring that cognitive and dementia care specialists are accessible to all, investing in health education in communities that have historically been overlooked, and continuing to pursue systemic changes that reduce poverty, improve education, and decrease chronic stress. The good news is that many of the interventions that reduce dementia risk—controlling blood pressure, managing diabetes, regular physical activity, cognitive engagement, and social connection—are equally beneficial for everyone and do not require expensive or specialized resources.
Conclusion
Dementia risk does indeed differ by race and ethnicity, and these differences reflect a combination of healthcare access, cardiovascular health, socioeconomic factors, educational attainment, and genetic variation. The disparities are not fixed or inevitable—they are the product of identifiable factors that can be addressed through better healthcare, community investment, and systemic change. For individuals and families concerned about dementia risk, this means that your race or ethnicity is one data point among many, and there are concrete steps you can take regardless of your background: manage blood pressure and blood sugar, maintain cognitive engagement, exercise regularly, and ensure you have regular access to healthcare providers who take your concerns seriously.
If you are from a racial or ethnic group with higher documented dementia risk, this information is not meant to cause alarm, but rather to encourage proactive engagement with your health. Talk with your doctor about your dementia risk, ask about cognitive screening as part of your regular care, and prioritize the modifiable risk factors you can control. For family members and caregivers, understanding these disparities can help explain why dementia might be more prevalent in your family or community, and it underscores the importance of early detection and aggressive management of risk factors like high blood pressure and diabetes.
